Hanson & Doremus Investment Management Abbott Laboratories Transaction History

Hanson & Doremus Investment Management

$748 Million
Q2 2025

A detailed history of Hanson & Doremus Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 20,340 shares of ABT stock, worth $2.72 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

20,340

Previous 25,398 19.91%

Holding current value

$2.72 Million

Previous $3.37 Million 17.9%

% of portfolio

0.37%

Previous 0.49%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	SELL	$123.95 - $138.08 $626,939 - $698,408	-5,058 Reduced 19.91%	20,340 $2.77 Million
Q1 2025 Apr 17, 2025	BUY	$111.1 - $140.22 $1.39 Million - $1.76 Million	12,522 Added 97.25%	25,398 $3.37 Million
Q4 2024 Jan 23, 2025	BUY	$111.93 - $119.39 $191,512 - $204,276	1,711 Added 15.32%	12,876 $1.46 Million
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $9,267 - $10,344	92 Added 0.83%	11,165 $1.16 Million
Q1 2024 Apr 22, 2024	SELL	$109.52 - $120.96 $33,732 - $37,255	-308 Reduced 2.71%	11,073 $1.26 Million
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $19,210 - $23,515	-213 Reduced 1.84%	11,381 $1.25 Million
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $4,967 - $5,960	52 Added 0.45%	11,594 $1.12 Million
Q2 2023 Jul 18, 2023	SELL	$100.78 - $112.29 $1,410 - $1,572	-14 Reduced 0.12%	11,542 $1.26 Million
Q1 2023 Apr 18, 2023	SELL	$96.86 - $114.01 $561,206 - $660,573	-5,794 Reduced 33.39%	11,556 $1.17 Million
Q4 2022 Jan 18, 2023	BUY	$95.06 - $111.52 $495,452 - $581,242	5,212 Added 42.94%	17,350 $1.91 Million
Q3 2022 Oct 20, 2022	SELL	$96.76 - $112.03 $4,450 - $5,153	-46 Reduced 0.38%	12,138 $1.17 Million
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $9,492 - $11,473	-93 Reduced 0.76%	12,184 $1.32 Million
Q1 2022 Apr 22, 2022	BUY	$114.02 - $139.04 $212,989 - $259,726	1,868 Added 17.95%	12,277 $1.45 Million
Q4 2021 Jan 20, 2022	SELL	$115.53 - $141.46 $12,477 - $15,277	-108 Reduced 1.03%	10,409 $1.47 Million
Q3 2021 Oct 21, 2021	SELL	$116.66 - $129.06 $66,379 - $73,435	-569 Reduced 5.13%	10,517 $1.24 Million
Q2 2021 Jul 22, 2021	SELL	$105.79 - $124.53 $502,185 - $591,143	-4,747 Reduced 29.98%	11,086 $1.21 Million
Q1 2021 May 03, 2021	SELL	$108.84 - $128.23 $67,263 - $79,246	-618 Reduced 3.76%	15,833 $1.9 Million
Q4 2020 Feb 01, 2021	BUY	$105.0 - $114.42 $563,325 - $613,863	5,365 Added 48.39%	16,451 $1.8 Million
Q3 2020 Oct 19, 2020	BUY	$91.64 - $111.29 $1,282 - $1,558	14 Added 0.13%	11,086 $1.21 Million
Q2 2020 Jul 17, 2020	SELL	$76.57 - $98.0 $578,562 - $740,488	-7,556 Reduced 40.56%	11,072 $1.01 Million
Q1 2020 Apr 24, 2020	BUY	$62.82 - $91.86 $464,428 - $679,120	7,393 Added 65.8%	18,628 $1.47 Million
Q3 2019 Oct 18, 2019	SELL	$81.84 - $88.74 $55,651 - $60,343	-680 Reduced 5.71%	11,235 $940,000
Q2 2019 Jul 18, 2019	BUY	$72.88 - $85.0 $84,686 - $98,770	1,162 Added 10.81%	11,915 $1 Million
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $45,824 - $55,401	-692 Reduced 6.05%	10,753 $0
Q4 2018 Jan 31, 2019	SELL	$65.56 - $74.27 $14,554 - $16,487	-222 Reduced 1.9%	11,445 $828,000
Q2 2018 Aug 08, 2018	SELL	$57.57 - $63.54 $451,866 - $498,725	-7,849 Reduced 40.22%	11,667 $709,000
Q1 2018 May 10, 2018	BUY	$56.27 - $63.62 $424,838 - $480,331	7,550 Added 63.1%	19,516 $1.17 Million
Q4 2017 Jan 25, 2018	SELL	$53.68 - $57.47 $9,662 - $10,344	-180 Reduced 1.48%	11,966 $683,000
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $583,736 - $651,511	12,146	12,146 $0

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $234B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Account

Hanson & Doremus Investment Management Abbott Laboratories Transaction History